Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients
with chronic renal failure: comparative study.
Liou HH, Chiang SS, Wu SC, Huang TP, Campese VM, Smogorzewski M, Yang WC
American Journal of Kidney Diseases. 1994 Feb;23:26671: Issue: 2
"Heart rate increased significantly after both treatments, but less after
nebulization than after infusion. It is concluded that both infusion and
nebulization are simple, effective, and safe therapeutic modalities for the treatment of
hyperkalemia in patients with chronic renal failure. Infusion should be
used in patients requiring a rapid decrease in plasma potassium; nebulization,
on the other hand, should be used in patients with coronary artery diseases".